Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity

被引：7
|
作者：
Torras, J [1 ]
Figueras, J [1 ]
Lama, C [1 ]
Fabregat, J [1 ]
Ramos, E [1 ]
Rafecas, A [1 ]
Gil-Vernet, S [1 ]
Pares, D [1 ]
Busquets, J [1 ]
Jaurrieta, E [1 ]
机构：
[1] CSU Bellvitge, Liver Transplant Unit, Barcelona, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(99)00462-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2430 / 2430
页数：1
相关论文
共 50 条
  • [11] Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity
    Yang, CW
    Ahn, HJ
    Kim, WY
    Li, C
    Kim, HW
    Choi, BS
    Cha, JH
    Kim, YS
    Kim, J
    Bang, BK
    KIDNEY INTERNATIONAL, 2002, 62 (01) : 20 - 30
  • [12] Mycophenolate mofetil (MMF) in pediatric liver transplant recipients
    Dhawan, A
    Lewis, PN
    Heaton, ND
    Baker, AJ
    Rela, M
    Hadzic, N
    Srinivasan, P
    MieliVergani, G
    HEPATOLOGY, 1997, 26 (04) : 1487 - 1487
  • [13] CONVERSION TO MYCOPHENOLATE MOFETIL MONOTHERAPY IN LIVER TRANSPLANT RECIPIENTS
    Kriss, Michael
    Abecassis, Michael M.
    Welti, Mary K.
    Sotil, Eva
    Levitsky, Josh
    HEPATOLOGY, 2009, 50 (04) : 570A - 570A
  • [14] Mycophenolate mofetil rescue therapy in liver transplant recipients
    Gavlik, A
    Goldberg, MG
    Tsaroucha, A
    Webb, MG
    Khan, RT
    Weppler, D
    Nery, JR
    Khan, MF
    Zucker, K
    Viciana, AL
    Miller, JA
    Tzakis, AG
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 549 - 552
  • [15] Mycophenolate mofetil in cyclosporine-associated nephrotoxicity
    Ducloux, D
    Fournier, V
    Bresson-Vautrin, C
    Rebibou, JM
    Saint-Hillier, Y
    Chalopin, JM
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (06) : 2825 - 2827
  • [16] Successful rescue therapy with mycophenolate mofetil in liver transplant recipients
    Graziadei, L
    Schulz, F
    Nachbaur, K
    Königsrainer, A
    Margreiter, R
    Vogel, W
    TRANSPLANTATION, 1999, 67 (07) : S192 - S192
  • [17] Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine
    Lee, CM
    Markezich, AJ
    Scandling, JD
    Dafoe, DC
    Alfrey, EJ
    JOURNAL OF SURGICAL RESEARCH, 1998, 76 (02) : 131 - 136
  • [18] Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil
    Tojimbara, T
    Sato, S
    Koyama, I
    Nanmoku, K
    Sekijima, M
    Tonsyo, M
    Kai, K
    Kato, Y
    Urashima, Y
    Nakajima, I
    Fuchinoue, S
    Teraoka, S
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 895 - 898
  • [19] Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy
    Sánchez, V
    Delgado, JF
    Blasco, T
    Dalmau, R
    Morales, JM
    Escribano, P
    Tello, R
    Hernández, J
    Velázquez, T
    Sotelo, T
    Gómez-Sánchez, MA
    de la Calzada, CS
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2515 - 2516
  • [20] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporin.
    Lobritto, SJ
    Rosenthal, P
    Bouw, R
    Leung, M
    Snell, P
    Mamelok, R
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 114 - 115
12345